Related Experiment Videos

Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells

D D Browning1, Z K Pan, E R Prossnitz

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.

Insights

The chemotactic peptide fMet-Leu-Phe (fMLF) activates nuclear factor-kappaB (NF-kappaB), a key inflammatory regulator. This activation is cell-specific and depends on myeloid differentiation, highlighting a novel signaling pathway.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Chemoattractants trigger phagocytic functions like migration and superoxide generation.
  • Nuclear factor-kappaB (NF-kappaB) is a crucial transcription factor for immediate-early inflammatory gene expression.

Purpose of the Study:

  • To investigate if the chemotactic peptide fMet-Leu-Phe (fMLF) activates NF-kappaB.
  • To determine the cell-specificity and regulatory mechanisms of fMLF-induced NF-kappaB activation.

Main Methods:

  • Peripheral blood mononuclear cells and HL-60 cells (transfected with N-formyl peptide receptor, FPR) were used.
  • NF-kappaB activation was assessed by measuring kappaB binding activity.
  • HL-60 cells were differentiated using dimethyl sulfoxide.

Main Results:

  • fMLF induced NF-kappaB activation in a receptor-dependent manner, involving p50 and p65 subunits.
  • NF-kappaB activation by fMLF was cell-specific and distinct from tumor necrosis factor-alpha (TNFalpha) activation.
  • Differentiated HL-60 cells gained the ability to activate NF-kappaB in response to fMLF.

Conclusions:

  • NF-kappaB is a transcription factor activated by the chemotactic peptide fMLF.
  • fMLF-induced NF-kappaB activation is tightly regulated and requires specific signaling components present during myeloid differentiation.

Related Concept Videos